Literature DB >> 3935171

Crystallization of pig skeletal phosphorylase b. Purification, physical and catalytic characterization.

N G Oikonomakos, A E Melpidou, L N Johnson.   

Abstract

A new method for purification and crystallization of pig skeletal muscle phosphorylase b is presented. The ease of crystallization in the presence of 1 mM AMP and 1 mM spermine has permitted the study of some physical, chemical and enzymatic properties of the enzyme. The crystalline pig phosphorylase b gave a single band on SDS polyacrylamide gels of the same mobility as rabbit muscle phosphorylase subunit. Ultracentrifugation experiments showed that pig phosphorylase b exists in a dimeric form (S20,w = 8.4 S). No association occurred at 20 degrees C under conditions where rabbit phosphorylase b can be tetramerized; pig phosphorylase b was only 30% associated from dimer to tetramer at 13 degrees C. Pig phosphorylase b is highly stable to freezing and its specific activity did not change appreciably upon prolonged storage in the cold. Pig and rabbit phosphorylases b have comparable Vmax and Km values towards the substrate and the activator. However, there is an essential difference between the two enzymes in that pig phosphorylase b is not significantly inhibited by glucose 6-phosphate, which is a powerful inhibitor of the rabbit enzyme. Two different crystal forms of pig phosphorylase b were obtained which are small for X-ray diffraction studies. Diffusion of spermine into tetragonal crystals of rabbit phosphorylase b resulted in a difference Fourier synthesis at 3 A resolution that showed no strong indication of specific binding.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3935171     DOI: 10.1016/0167-4838(85)90257-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Effects of commonly used cryoprotectants on glycogen phosphorylase activity and structure.

Authors:  K E Tsitsanou; N G Oikonomakos; S E Zographos; V T Skamnaki; M Gregoriou; K A Watson; L N Johnson; G W Fleet
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

2.  Activator anion binding site in pyridoxal phosphorylase b: the binding of phosphite, phosphate, and fluorophosphate in the crystal.

Authors:  N G Oikonomakos; S E Zographos; K E Tsitsanou; L N Johnson; K R Acharya
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

3.  The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100 K: the role of the water structure and its contribution to binding.

Authors:  M Gregoriou; M E Noble; K A Watson; E F Garman; T M Krulle; C de la Fuente; G W Fleet; N G Oikonomakos; L N Johnson
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

4.  Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1, 3, 4-oxadiazole, -benzothiazole, and -benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site.

Authors:  Evangelia D Chrysina; Magda N Kosmopoulou; Constantinos Tiraidis; Rozina Kardakaris; Nicolas Bischler; Demetres D Leonidas; Zsuzsa Hadady; Laszlo Somsak; Tibor Docsa; Pal Gergely; Nikos G Oikonomakos
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

5.  The binding of D-gluconohydroximo-1,5-lactone to glycogen phosphorylase. Kinetic, ultracentrifugation and crystallographic studies.

Authors:  A C Papageorgiou; N G Oikonomakos; D D Leonidas; B Bernet; D Beer; A Vasella
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

6.  Laue and monochromatic diffraction studies on catalysis in phosphorylase b crystals.

Authors:  E M Duke; S Wakatsuki; A Hadfield; L N Johnson
Journal:  Protein Sci       Date:  1994-08       Impact factor: 6.725

7.  The design of potential antidiabetic drugs: experimental investigation of a number of beta-D-glucose analogue inhibitors of glycogen phosphorylase.

Authors:  N G Oikonomakos; M Kontou; S E Zographos; H S Tsitoura; L N Johnson; K A Watson; E P Mitchell; G W Fleet; J C Son; C J Bichard
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jul-Sep       Impact factor: 2.441

8.  FR258900, a potential anti-hyperglycemic drug, binds at the allosteric site of glycogen phosphorylase.

Authors:  Costas Tiraidis; Kyra-Melinda Alexacou; Spyros E Zographos; Demetres D Leonidas; Thanasis Gimisis; Nikos G Oikonomakos
Journal:  Protein Sci       Date:  2007-06-28       Impact factor: 6.725

9.  Catalysis in the crystal: synchrotron radiation studies with glycogen phosphorylase b.

Authors:  J Hajdu; K R Acharya; D I Stuart; P J McLaughlin; D Barford; N G Oikonomakos; H Klein; L N Johnson
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.